2026 Health Policy Update: Key Developments in Washington and the Outlook for 2027

Thursday, July 23, 2026

The U.S. healthcare policy environment continues to evolve at a significant pace, with consequential activity underway across drug pricing, patient access, coverage, and biopharmaceutical innovation. For life sciences manufacturers, understanding the legislative and regulatory developments shaping the market access landscape is critical to informing strategic planning.

During this live webinar, experts from Magnolia Market Access and Latham & Watkins provide a comprehensive review of key healthcare policy developments in Washington in 2026, along with a forward-looking perspective on what stakeholders should anticipate heading into 2027.

Topics include current drug pricing policy and negotiation frameworks, evolving formulary and coverage dynamics, legislative activity affecting patient access, and the implications of ongoing regulatory change for the innovation pipeline.

Why Watch:
In this session, you will gain a unique perspective from a timely discussion on key 2026 healthcare policy developments in Washington and what they may mean for drug pricing, patient access, coverage, biopharmaceutical innovation, and strategic planning heading into 2027.